OnCo
termsTerm

Obstructive jaundice and biliary obstruction

aka jaundice, obstructive jaundice, biliary obstruction, bile duct obstruction, cholestasis, cholangitis, bilirubin, elevated bilirubin, hyperbilirubinaemia, hyperbilirubinemia, biliary drainage, pruritus from cholestasis, malignant bowel obstruction, bowel obstruction, intestinal obstruction, gastric outlet obstruction, airway obstruction, SVC syndrome, superior vena cava syndrome, ureteric obstruction, hydronephrosis

Yellowing of the skin and eyes because a tumour blocks the bile duct, most often pancreatic or bile duct cancer. It causes itching, infection risk and dark urine, and it must be relieved (usually with a stent) before chemotherapy can be given safely.

Most pancreatic head, distal bile duct and ampullary cancers present with painless jaundice; perihilar cholangiocarcinoma obstructs higher up. Bilirubin above about 1.5× normal precludes most chemotherapy (irinotecan, taxanes and many TKIs are cleared by the liver), so ERCP-placed metal stents or percutaneous drainage come first, with antibiotics for cholangitis. Other malignant obstructions treated by stenting, surgery or radiotherapy include gastric outlet, bowel (managed medically with octreotide and steroids in advanced disease, or surgically), airway, superior vena cava (SVC syndrome) and ureteric obstruction causing hydronephrosis, which impairs cisplatin eligibility in bladder and cervical cancer.

Category
Side effects

Connected

7top